March 16, 2017 / 11:28 AM / 5 months ago

BRIEF-Titan Pharmaceuticals posts Q4 loss per share $0.11

March 16 (Reuters) - Titan Pharmaceuticals Inc

* Titan pharmaceuticals reports full year and fourth quarter 2016 financial results

* Q4 loss per share $0.11

* At dec. 31, 2016, co had cash of approximately $14.0 million, compared with approximately $7.9 million at dec. 31, 2015

* Its working capital at Dec. 31, 2016 is sufficient to fund operations through Q1 of 2018 Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below